Search Results - "Donath, Marc Y."

Refine Results
  1. 1

    Targeting inflammation in the treatment of type 2 diabetes: time to start by Donath, Marc Y.

    Published in Nature reviews. Drug discovery (01-06-2014)
    “…Key Points Inflammation has an important role in the pathogenesis of type 2 diabetes and associated complications. Clinical studies have demonstrated that…”
    Get full text
    Journal Article
  2. 2

    Type 1 diabetes: what is the role of autoimmunity in β cell death? by Donath, Marc Y

    Published in The Journal of clinical investigation (17-10-2022)
    “…The current dogma of type 1 diabetes pathogenesis asserts that an autoimmune attack leads to the destruction of pancreatic β cells, with subsequent…”
    Get full text
    Journal Article
  3. 3

    Inflammation in the Pathophysiology and Therapy of Cardiometabolic Disease by Donath, Marc Y, Meier, Daniel T, Böni-Schnetzler, Marianne

    Published in Endocrine reviews (01-08-2019)
    “…Abstract The role of chronic inflammation in the pathogenesis of type 2 diabetes mellitus and associated complications is now well established. Therapeutic…”
    Get full text
    Journal Article
  4. 4

    Inflammation in Obesity and Diabetes: Islet Dysfunction and Therapeutic Opportunity by Donath, Marc Y., Dalmas, Élise, Sauter, Nadine S., Böni-Schnetzler, Marianne

    Published in Cell metabolism (04-06-2013)
    “…The role of the immune system is to restore functionality in response to stress. Increasing evidence shows that this function is not limited to insults by…”
    Get full text
    Journal Article
  5. 5

    The IL-1 Pathway in Type 2 Diabetes and Cardiovascular Complications by Herder, Christian, Dalmas, Elise, Böni-Schnetzler, Marianne, Donath, Marc Y

    Published in Trends in endocrinology and metabolism (01-10-2015)
    “…Patients with type 2 diabetes (T2D) exhibit chronic activation of the innate immune system in pancreatic islets, in insulin-sensitive tissues, and at sites of…”
    Get full text
    Journal Article
  6. 6

    The Role of Inflammation in β-cell Dedifferentiation by Nordmann, Thierry M., Dror, Erez, Schulze, Friederike, Traub, Shuyang, Berishvili, Ekaterine, Barbieux, Charlotte, Böni-Schnetzler, Marianne, Donath, Marc Y.

    Published in Scientific reports (24-07-2017)
    “…Chronic inflammation impairs insulin secretion and sensitivity. β-cell dedifferentiation has recently been proposed as a mechanism underlying β-cell failure in…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Cystine/Glutamate antiporter system xc- deficiency impairs macrophage glutathione metabolism and cytokine production by de Baat, Axel, Meier, Daniel T., Fontana, Adriano, Böni-Schnetzler, Marianne, Donath, Marc Y.

    Published in PloS one (04-10-2023)
    “…System x c - , encoded by Slc7a11 , is an antiporter responsible for exporting glutamate while importing cystine, which is essential for protein synthesis and…”
    Get full text
    Journal Article
  9. 9

    Evidence for cephalic phase insulin release in humans: A systematic review and meta-analysis by Wiedemann, Sophia J., Rachid, Leila, Illigens, Ben, Böni-Schnetzler, Marianne, Donath, Marc Y.

    Published in Appetite (01-12-2020)
    “…The initial release of insulin in response to food stimuli acting on receptors in the head and oropharynx is called the cephalic phase of insulin secretion…”
    Get full text
    Journal Article
  10. 10

    Interleukin-1–Receptor Antagonist in Type 2 Diabetes Mellitus by Larsen, Claus M, Faulenbach, Mirjam, Vaag, Allan, Vølund, Aage, Ehses, Jan A, Seifert, Burkhardt, Mandrup-Poulsen, Thomas, Donath, Marc Y

    Published in The New England journal of medicine (12-04-2007)
    “…The expression of interleukin-1–receptor antagonist is reduced in pancreatic islets in type 2 diabetes, and high glucose concentrations induce interleukin-1β…”
    Get full text
    Journal Article
  11. 11

    Sustained Effects of Interleukin-1 Receptor Antagonist Treatment in Type 2 Diabetes by Larsen, Claus M, Faulenbach, Mirjam, Vaag, Allan, Ehses, Jan A, Donath, Marc Y, Mandrup-Poulsen, Thomas

    Published in Diabetes care (01-09-2009)
    “…OBJECTIVE: Interleukin (IL)-1 impairs insulin secretion and induces β-cell apoptosis. Pancreatic β-cell IL-1 expression is increased and interleukin-1 receptor…”
    Get full text
    Journal Article
  12. 12

    Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes by CAVELTI-WEDER, Claudia, BABIANS-BRUNNER, Andrea, KELLER, Cornelia, STAHEL, Marc A, KURZ-LEVIN, Malaika, ZAYED, Hany, SOLINGER, Alan M, MANDRUP-POULSEN, Thomas, DINARELLO, Charles A, DONATH, Marc Y

    Published in Diabetes care (01-08-2012)
    “…Metabolic activation of the innate immune system governed by interleukin (IL)-1β contributes to β-cell failure in type 2 diabetes. Gevokizumab is a novel,…”
    Get full text
    Journal Article
  13. 13

    Nivolumab-induced diabetes mellitus-a case report with literature review of the treatment options by Daetwyler, Eveline, Zippelius, Alfred, Danioth, Simona, Donath, Marc Y, Gut, Lara

    Published in Frontiers in immunology (26-10-2023)
    “…Immune checkpoint inhibitor (ICI) treatment has become important for treating various cancer types, including metastatic renal cell carcinoma. However, ICI…”
    Get full text
    Journal Article
  14. 14

    Cardiac evaluation in amiodarone-induced thyroid dysfunction with suspected cardiac ischemia?: a case report and review of the literature by Aubry, Yoann, Dosch, Michel, Donath, Marc Y

    Published in Journal of medical case reports (02-05-2024)
    “…Amiodarone-induced thyroid dysfunction (AIT) is a side-effect associated with the use of Amiodarone for the treatment of refractory arrythmias. Resulting…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Cytokine production by islets in health and diabetes: cellular origin, regulation and function by Donath, Marc Y, Böni-Schnetzler, Marianne, Ellingsgaard, Helga, Halban, Philippe A, Ehses, Jan A

    Published in Trends in endocrinology and metabolism (01-05-2010)
    “…Islets produce a variety of cytokines and chemokines in response to physiologic and pathologic stimulation by nutrients. The cellular source of these…”
    Get full text
    Journal Article
  17. 17

    Free Fatty Acids Induce a Proinflammatory Response in Islets via the Abundantly Expressed Interleukin-1 Receptor I by Böni-Schnetzler, Marianne, Boller, Simone, Debray, Sarah, Bouzakri, Karim, Meier, Daniel T, Prazak, Richard, Kerr-Conte, Julie, Pattou, Francois, Ehses, Jan A, Schuit, Frans C, Donath, Marc Y

    Published in Endocrinology (Philadelphia) (01-12-2009)
    “…Islets of patients with type 2 diabetes mellitus (T2DM) display features of an inflammatory process including elevated levels of the cytokine IL-1β, various…”
    Get full text
    Journal Article
  18. 18

    Distinct Transcriptional Responses across Tissue-Resident Macrophages to Short-Term and Long-Term Metabolic Challenge by Brykczynska, Urszula, Geigges, Marco, Wiedemann, Sophia J., Dror, Erez, Böni-Schnetzler, Marianne, Hess, Christoph, Donath, Marc Y., Paro, Renato

    Published in Cell reports (Cambridge) (04-02-2020)
    “…The innate immune system safeguards the organism from both pathogenic and environmental stressors. Also, physiologic levels of nutrients affect organismal and…”
    Get full text
    Journal Article
  19. 19

    Increased Number of Islet-Associated Macrophages in Type 2 Diabetes by EHSES, Jan A, PERREN, Aurel, FONTANA, Adriano, REINECKE, Manfred, HOMO-DELARCHE, Francoise, DONATH, Marc Y, EPPLER, Elisabeth, RIBAUX, Pascale, POSPISILIK, John A, MAOR-CAHN, Ranit, GUERIPEL, Xavier, ELLINGSGAARD, Helga, SCHNEIDER, Marten K. J, BIOLLAZ, Gregoire

    Published in Diabetes (New York, N.Y.) (01-09-2007)
    “…Increased Number of Islet-Associated Macrophages in Type 2 Diabetes Jan A. Ehses 1 , Aurel Perren 2 , Elisabeth Eppler 3 , Pascale Ribaux 4 , John A…”
    Get full text
    Journal Article
  20. 20